Recessive Dystrophic Epidermolysis bullosa due to Hemizygous 40 kb Deletion of COL7A1 and the Proximate PFKFB4 Gene Focusing on the Mutation c.425A>G Mimicking Homozygous Status

COL7A1 Epidermolysis bullosa LAM-PCR MLPA RDEB deletion hemizygosity

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
11 10 2022
Historique:
received: 27 08 2022
revised: 17 09 2022
accepted: 28 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Background: Dystrophic Epidermolysis bullosa (DEB) is a rare inherited mechanobullous disease characterised by the hyperfragility of the skin and mucous membranes. It is (typically) caused by (loss-of-function) mutations in the COL7A1 gene that impair the formation of collagen type VII, which represents the major constituent of anchoring fibrils within the basement membrane zone of epithelialised tissues. In a 4-year-old patient diagnosed with the clinical features of recessive DEB, genotyping via Next-Generation EB Panel Sequencing initially revealed the homozygosity of the maternal c.425A>G mutation, while the paternal heterozygosity in exon 3 was lacking. This genetic profile suggested incongruent gene transmission due to uniparental isodisomy (UPD) or the occurrence of a hemizygous deletion of unknown size. Methods: Thus, the EB panel sequencing of genomic DNA, followed by a paternity test and analysis of microsatellite markers, as well as multiplex ligation-dependent probe amplification (MLPA) copy number analysis using patient and parental DNA, were performed. Results: This approach revealed a paternally derived hemizygous deletion spanning from exon 3 to exon 118. Linear amplification-mediated PCR (LAM-PCR) determined the breaking points within intron 2 of the COL7A1 gene, comprising a 40kb segment within intron 1 of the adjacent PFKFB4 gene. Conclusion: This report highlights the relevance of advanced molecular profiling to determine new/exceptional/unusual genotypes and the accurate mode of genetic transmission in DEB.

Identifiants

pubmed: 36292148
pii: diagnostics12102460
doi: 10.3390/diagnostics12102460
pmc: PMC9600310
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Dermatol. 2009 Nov;161(5):1089-97
pubmed: 19681861
PLoS Genet. 2010 Oct 14;6(10):e1001154
pubmed: 20976243
Br J Dermatol. 2005 May;152(5):879-86
pubmed: 15888141
J Am Acad Dermatol. 2008 Jun;58(6):931-50
pubmed: 18374450
Am J Med Genet A. 2005 Jul 30;136(3):287-305
pubmed: 15957160
Arch Dermatol Res. 2007 Jun;299(3):145-50
pubmed: 17415575
Genomics. 1994 May 1;21(1):169-79
pubmed: 8088784
Genet Med. 2012 Jun;14(6):594-603
pubmed: 22382802
J Invest Dermatol. 2014 Mar;134(3):849-852
pubmed: 24042343
Am J Hum Genet. 1997 Sep;61(3):611-9
pubmed: 9326326
Br J Dermatol. 2020 Oct;183(4):614-627
pubmed: 32017015
J Mol Diagn. 2005 Feb;7(1):28-35
pubmed: 15681471
Am J Hum Genet. 1997 Sep;61(3):599-610
pubmed: 9326325
Dev Growth Differ. 2020 Feb;62(2):129-138
pubmed: 31912488
J Dermatol Sci. 2008 Jul;51(1):58-61
pubmed: 18387282
J Dermatolog Treat. 2007;18(5):306-11
pubmed: 17852634
J Invest Dermatol. 2000 Aug;115(2):307-11
pubmed: 10951251
Am J Hum Genet. 1996 Aug;59(2):292-300
pubmed: 8755915
Cancers (Basel). 2021 Feb 22;13(4):
pubmed: 33671514
Clin Exp Dermatol. 2016 Jun;41(4):372-8
pubmed: 26940370
Nat Methods. 2007 Dec;4(12):1051-7
pubmed: 18049469
Acta Derm Venereol. 2020 Jan 30;100(1):adv00041
pubmed: 31502654
Life (Basel). 2022 Jan 30;12(2):
pubmed: 35207500
J Invest Dermatol. 1998 May;110(5):828-31
pubmed: 9579554
Clin Exp Dermatol. 2005 Jan;30(1):71-4
pubmed: 15663509
J Invest Dermatol. 2006 Sep;126(9):2039-43
pubmed: 16710310
J Invest Dermatol. 1999 Oct;113(4):673-86
pubmed: 10504458
Cells. 2022 Apr 17;11(8):
pubmed: 35456044
Hum Mutat. 2006 Mar;27(3):291-2
pubmed: 16470588
J Invest Dermatol. 1993 Apr;100(4):366-72
pubmed: 8454899
Hum Mutat. 1997;10(5):338-47
pubmed: 9375848
J Invest Dermatol. 1994 Nov;103(5 Suppl):39S-46S
pubmed: 7963683
Nat Genet. 1993 Nov;5(3):287-93
pubmed: 8275094
Exp Dermatol. 2008 Jul;17(7):553-68
pubmed: 18558993

Auteurs

Alfred Klausegger (A)

EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Niklas Jeschko (N)

EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Markus Grammer (M)

EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Jan Cemper-Kiesslich (J)

Department of Legal Medicine, University of Salzburg, 5020 Salzburg, Austria.

Franz Neuhuber (F)

Department of Legal Medicine, University of Salzburg, 5020 Salzburg, Austria.

Anja Diem (A)

EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Hannelore Breitenbach-Koller (H)

Department of Biosciences, University of Salzburg, 5020 Salzburg, Austria.

Gabriele Sander (G)

Institute of Human Genetics, Department of Pediatrics, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Dieter Kotzot (D)

Institute of Human Genetics, Department of Pediatrics, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

Johann Wolfgang Bauer (JW)

EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Martin Laimer (M)

EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Classifications MeSH